V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014097 | 160006911 | 1.62 | 103 | Curative (C) | 2017-08-06 | 2017-08-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101371957 |
| 160014098 | 160006912 | 0 | 65 | Disease modification (D) | 2019-05-30 | 2019-05-30 | DOXORUBICIN | null | N | DOXORUBICIN | 100495599 |
| 160014100 | 160006913 | 1.79 | 81.9 | Neo-adjuvant (N) | 2019-01-11 | 2019-01-16 | Bevacizumab 7.5mg/kg | 02 | N | TRIAL UNSPECIFIED | 100775582 |
| 160014105 | 160006914 | 1.61 | 72 | Curative (C) | 2016-10-21 | 2016-10-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100081806 |
| 160014107 | 160006915 | 1.83 | 10.4 | null | 2020-11-23 | 2020-11-24 | DOXORUBICIN | 02 | N | DOXORUBICIN + OLARATUMAB | 101291046 |
| 160014108 | 160006916 | 1.73 | 80.2 | Palliative (P) | 2019-06-24 | 2019-07-06 | Dactinomycin + Vincristine | N | N | ABIRATERONE | 100839556 |
| 160014109 | 160006917 | 0 | 61.8 | null | 2016-05-17 | 2016-06-03 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100238749 |
| 160014110 | 160006918 | 1.7 | 75.3 | 03 | null | 2019-12-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101054840 |
| 160014112 | 160006919 | 1.82 | 101 | Palliative (P) | 2016-02-25 | 2016-03-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100573813 |
| 160014113 | 160006920 | 1.67 | 62 | Palliative (P) | 2020-01-09 | 2020-01-23 | DACARBAZINE + DOXORUBICIN | null | N | BEVACIZUMAB + CARBO + PACLITAXEL | 101038314 |
| 160014114 | 160006921 | 1.82 | null | Palliative (P) | 2016-02-03 | 2016-02-10 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 101744156 |
| 160014117 | 160006922 | 1.72 | 41.4 | Palliative (P) | 2017-06-19 | 2017-06-23 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101109217 |
| 160014118 | 160006923 | 1.83 | 77.2 | null | 2018-09-04 | 2018-09-14 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101297872 |
| 160014119 | 160006924 | 1.62 | 40.9 | Palliative (P) | 2016-07-25 | 2016-07-25 | DOXORUBICIN | null | null | DOXORUBICIN | 101716450 |
| 160014120 | 160006925 | 1.54 | 0 | Palliative (P) | 2019-06-28 | 2019-07-17 | ETOP 13-18 BEAT-meso Trial | null | null | BEVACIZUMAB | 101591862 |
| 160014122 | 160006926 | 1.64 | 94.4 | Adjuvant (A) | 2017-07-24 | 2017-08-03 | Doxorubicin + Olaratumab | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100791141 |
| 160014123 | 160006927 | 1.71 | 67.8 | null | 2019-08-24 | 2019-09-02 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101206814 |
| 160014125 | 160006928 | 1.81 | 100 | Palliative (P) | 2017-11-08 | 2017-11-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | CARBOPLATIN + PACLITAXEL | 101613467 |
| 160014133 | 160006929 | 1.8 | 74.2 | Palliative (P) | 2016-11-09 | 2016-11-23 | null | 02 | Y | EW EUROEWING 2012 ARM B VDC | 100503299 |
| 160014134 | 160006930 | 1.73 | 79.1 | null | 2016-07-27 | 2016-07-30 | ETOP 13-18 BEAT-meso Trial | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101494567 |
| 160014136 | 160006931 | 1.65 | 91.5 | Neo-adjuvant (N) | 2019-10-06 | 2019-10-08 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101092713 |
| 160014138 | 160006932 | 1.74 | 104 | Neo-adjuvant (N) | 2016-10-01 | 2016-11-03 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100667969 |
| 160014142 | 160006933 | 1.59 | 91.6 | Palliative (P) | 2019-09-19 | 2019-10-01 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100891848 |
| 160014143 | 160006934 | 1.76 | 61.75 | null | 2022-04-23 | 2022-04-27 | Doxorubicin 75mg/m2 | 02 | N | EW EUROEWING 2012 ARM B VDC | 100218003 |
| 160014146 | 160006935 | 0 | 14 | null | 2020-07-22 | 2020-07-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101460595 |
| 160014147 | 160006936 | 1.67 | 107.1 | Palliative (P) | 2020-01-15 | 2020-01-29 | BEP 5 Day | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101727318 |
| 160014149 | 160006937 | 1.81 | 84.8 | Palliative (P) | 2018-03-15 | 2018-03-21 | DOXORUBICIN | N | N | VINORELBINE | 101725139 |
| 160014152 | 160006938 | 1.56 | 67.1 | null | 2016-09-08 | 2019-02-19 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100314723 |
| 160014156 | 160006939 | 1.64 | 10.7 | Palliative (P) | 2019-04-07 | 2019-04-12 | Doxorubicin + Ifosfamide | N | N | CARBOPLATIN + PACLITAXEL | 101788832 |
| 160014158 | 160006940 | 1.71 | 73.9 | Neo-adjuvant (N) | 2019-01-14 | 2019-01-15 | ECF | 02 | null | NOT MATCHED | 100927187 |
| 160014159 | 160006941 | 0 | 0 | Palliative (P) | 2019-12-06 | 2019-12-08 | DOXORUBICIN | N | N | LIPOSOMAL DOXORUBICIN | 101077547 |
| 160014160 | 160006942 | 1.55 | 104 | 03 | 2016-08-29 | 2016-08-29 | EW EuroEwing 2012 Arm B VDC | 02 | N | CARBOPLATIN + GEMCITABINE | 101205055 |
| 160014164 | 160006943 | 1.63 | 78 | Palliative (P) | 2014-09-24 | 2014-10-01 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100651428 |
| 160014165 | 160006944 | 1.72 | 59.8 | Palliative (P) | 2017-10-27 | 2017-10-27 | ICON8B TRIAL | 02 | N | VIDE | 100084199 |
| 160014166 | 160006945 | 1.78 | 49.1 | Palliative (P) | 2016-12-06 | 2016-12-15 | Bevacizumab+Carbo+Pacliaxel | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101646726 |
| 160014167 | 160006946 | 1.74 | 100 | Palliative (P) | 2020-02-18 | 2020-03-09 | Bevacizumab 7.5mg/kg | 02 | N | TRIAL | 100176565 |
| 160014169 | 160006947 | 1.74 | 61.1 | Curative (C) | 2018-06-26 | 2018-07-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100534899 |
| 160014171 | 160006948 | 1.78 | 84.9 | Palliative (P) | 2018-04-10 | 2018-04-12 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 101021221 |
| 160014172 | 160006949 | 1.69 | 85 | null | 2020-08-14 | 2020-08-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100479425 |
| 160014174 | 160006950 | 1.8 | 79.7 | Curative (C) | 2016-04-12 | 2016-04-20 | BORTEZOMIB + THALIDOMIDE | 02 | N | TRIAL | 101034093 |
| 160014177 | 160006951 | 1.78 | 69.5 | Palliative (P) | 2016-11-19 | 2016-12-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100499256 |
| 160014182 | 160006952 | 1.75 | 70.5 | Palliative (P) | 2019-11-24 | 2019-12-03 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101144946 |
| 160014186 | 160006953 | 1.54 | 55 | Palliative (P) | 2017-12-11 | 2017-12-12 | Doxorubicin + Ifosfamide | N | Y | MELPHALAN | 101753059 |
| 160014192 | 160006954 | 1.73 | 91 | null | 2016-09-18 | 2016-09-18 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100270220 |
| 160014196 | 160006956 | 1.55 | 59.8 | Palliative (P) | 2018-11-26 | 2018-12-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101630269 |
| 160014199 | 160006957 | 1.79 | 67.3 | Palliative (P) | null | 2018-01-08 | Liposomal Doxorubicin (Caelyx) | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101381247 |
| 160014201 | 160006958 | 1.86 | 108.4 | null | 2019-07-07 | 2019-07-15 | Doxorubicin + Olaratumab | Y | N | CARBOPLATIN + GEMCITABINE | 100414099 |
| 160014209 | 160006959 | 1.64 | 91 | Palliative (P) | null | null | IVA | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101336868 |
| 160014212 | 160006960 | 0 | 93.5 | Palliative (P) | 2017-09-06 | 2017-09-16 | Paclitaxel (2 or 3 weekly) | N | N | DOXORUBICIN | 100568521 |
| 160014215 | 160006961 | 0 | 70.3 | Curative (C) | 2016-08-15 | 2016-09-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100109822 |